| RGAHX | RRGSX | RGAHX / RRGSX | |
| Total Expense Ratio | 0.44 | 1.16 | 38% |
| Annual Report Gross Expense Ratio | 0.44 | 1.16 | 38% |
| Fund Existence | 10 years | 23 years | - |
| Gain YTD | 9.123 | 1.429 | 638% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 2500 | 10% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 339B | 51.4B | 660% |
| Annual Yield % from dividends | 0.44 | 0.00 | - |
| Returns for 1 year | 5.75 | -2.06 | -279% |
| Returns for 3 years | 65.91 | 70.28 | 94% |
| Returns for 5 years | 23.10 | 7.51 | 308% |
| Returns for 10 years | 96.48 | 87.05 | 111% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| EARN | 5.28 | 0.04 | +0.76% |
| Ellington Credit Company | |||
| IDNA | 26.94 | 0.15 | +0.56% |
| iShares Genomics Immnlgy & Hlthcr ETF | |||
| VCR | 403.80 | 1.27 | +0.32% |
| Vanguard Consumer Discretionary ETF | |||
| CCD | 21.67 | 0.06 | +0.28% |
| Calamos Dynamic Convertible & Income Fund | |||
| UPV | 90.22 | -0.78 | -0.86% |
| ProShares Ultra FTSE Europe | |||